During the Health System Executive Summit, Candy Tsourounis, PharmD, and Elise Wozniak, PharmD got candid about the barriers and financial risk surrounding this innovative therapy.
News|Articles|May 1, 2010
First-time generic approvals May 2010
Generic drugs approved by FDA (through April 2010): Losartan potassium tablets in 25-mg, 50-mg, and 100-mg, Losartan potassium and hydrochlorothiazide tablets in 50 mg/12.5 mg, 100 mg/12.5-mg, and 100 mg/25 mg, Hydromorphone hydrochloride injection, Mesna injection
Advertisement
Losartan potassium tablets in 25-mg, 50-mg, and 100-mg strengths (equiv to Cozaar)
TEVA PHARMACEUTICALS
Losartan potassium and hydrochlorothiazide tablets in 50 mg/12.5 mg, 100 mg/12.5-mg, and 100 mg/25 mg strengths (equiv to Hyzaar)
Hydromorphone hydrochloride injection 10 mg/mL in 1-, 5-, and 50-mL doses (equiv to Dilaudid-HP 10 mg/mL injection)
AKORN
Mesna injection in 1 mg per 10 mL multi-dose vials (equiv to Mesnex)
STRIDES ARCOLAB
Advertisement
Related to this article
Robotic lobectomies grew from 49% to 70% of cases from 2020 to 2024 as access and training expanded, says Staci Beamer, M.D., of HonorHealth.
AI analyzes single-lead ECGs from sleep studies to predict atrial fibrillation, heart failure, and mortality risk, enabling scalable cardiovascular disease screening.
Consistent bedtime routines, screen-free bedrooms and therapist support for night waking help children with ADHD sleep better, said Alison Pritchard, Ph.D.
Jamilia Sherls, DNP, MPH, RN, CPN, CDP, of Washington’s health department says health systems should look to AAP and AAFP schedules and build on patients’ trust in providers.
Jamilia Sherls, DNP, MPH, RN, CPN, CDP, of Washington’s health department says a stayed schedule overhaul cutting recommended child vaccines from 17 to 11 could upend coverage.
The American College of Chest Physicians and the European Respiratory Society issued bronchiectasis guidelines recently. Here is a comparison.
Experts discussed guidelines from the American College of Chest Physicians and the European Respiratory Society at the 2026 CHEST meeting in Phoenix earlier this week.
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Apothecary Pharma recalls compounded tirzepatide and NAD+ vials over sterility concerns
2
Heart data in sleep study predicts atrial fibrillation, heart failure years in advance
3
For bronchiectasis, a new era of guideline-guided care | CHEST 2026
4
Now is the time to get ready for 2027 changes in prior authorization, MA Star Ratings and others in federal healthcare law and regulations
5